Vaxcyte, Inc.宣布其Vax-31婴儿2期剂量探索研究取得进展,首批参与试验的受试者已开始接受Vax-31优化剂量的给药治疗。
Vaxcyte, Inc.宣布其Vax-31婴儿2期剂量探索研究取得进展,首批参与试验的受试者已开始接受Vax-31优化剂量的给药治疗。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.